Efficacy and Safety of Tegoprazan Dual Therapy and Furazolidone-based Bismuth Quadruple Therapy for Helicobacter Pylori Eradication: A Prospective, Multicenter, Open-label, Randomized Controlled Clinical Study

ClinicalTrials.gov · COMPLETED, 2025

400 participants

Abstract

To compare the efficacy and safety of Tegoprazan-amoxicillin dual therapy and bismuth quadruple therapy based on furazolidone in the treatment of Helicobacter pylori eradication, the eradication rate, patient compliance, and adverse drug reactions of H. pylori infection were compared in a multi-center clinical joint study in Jiangsu Province.

Conditions: Helicobacter Pylori Infection, Tegoprazan, Furazolidone.

Primary outcome: Helicobacter pylori eradication rate.

Enrollment: 400 participants.

How strong is the evidence?

Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design. Reported size: 400 participants or records.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

• ClinicalTrials.gov
• Publisher page

Related studies

• Prevalence and Characteristics of Autism Spectrum Disorder Among Children Aged 8 Years — Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2018 Morbidity and mortality weekly report. Surveillance summaries, 2021
• Improving sleep quality leads to better mental health: A meta-analysis of randomised controlled trials Sleep Medicine Reviews, 2021
• Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study Lancet. Infectious Diseases (Print), 2021
• Occupation and risk of severe COVID-19: prospective cohort study of 120,075 UK Biobank participants Occupational and Environmental Medicine, 2020
• Clinical presentation and virological assessment of confirmed human monkeypox virus cases in Spain: a prospective observational cohort study The Lancet, 2022
• Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, population-based retrospective cohort study The Lancet Respiratory Medicine, 2020

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free